Search - tctmd.com

Displaying 681 - 700 of 2009

Sort: Relevancy | Date

Amyloid Beta (1-40) Shows Promise as a Blood Marker to Risk Stratify NSTE ACS Patients

News Daily News

Amyloid Beta (1-40) Shows Promise as a Blood Marker to Risk Stratify NSTE ACS Patients

May 21, 2018

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

News Daily News

PCI Public Reporting: Where Some Point to Problems, Others Propose Solutions

May 09, 2018

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

News Daily News

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Michael O'Riordan

May 08, 2018

Plaque Dislodgement Less Frequent With Transradial vs Transfemoral PCI

News Daily News

Plaque Dislodgement Less Frequent With Transradial vs Transfemoral PCI

Michael O'Riordan

May 07, 2018

Some Sex Differences Disappear With an Improved STEMI Protocol

News Daily News

Some Sex Differences Disappear With an Improved STEMI Protocol

May 07, 2018

Alirocumab Price Slashed in Deal With Express Scripts

News Daily News

Alirocumab Price Slashed in Deal With Express Scripts

Michael O'Riordan

May 03, 2018

Certain CAD Subgroups Without Severe HF Face Heightened Risk of Sudden Cardiac Death

News Daily News

Certain CAD Subgroups Without Severe HF Face Heightened Risk of Sudden Cardiac Death

May 02, 2018

EMS Going Directly to PCI Centers Speeds Up STEMI Treatment

News Daily News

EMS Going Directly to PCI Centers Speeds Up STEMI Treatment

May 01, 2018

Seattle Angina Questionnaire Works Equally Well in Women

News Daily News

Seattle Angina Questionnaire Works Equally Well in Women

Michael O'Riordan

April 30, 2018

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

Less Bleeding, Similar Outcomes With Dual vs Triple Therapy After PCI in Patients With A-fib

News Daily News

Less Bleeding, Similar Outcomes With Dual vs Triple Therapy After PCI in Patients With A-fib

April 24, 2018

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

Remaining Active After MI May Help Stave Off Mortality

News Daily News

Remaining Active After MI May Help Stave Off Mortality

April 23, 2018

Nearly Half of Acute MI Patients Under Age 50 May Have Metabolic Syndrome

News Daily News

Nearly Half of Acute MI Patients Under Age 50 May Have Metabolic Syndrome

April 19, 2018

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

April 18, 2018

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

News Daily News

New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS

Yael L. Maxwell

April 18, 2018

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

News Daily News

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

April 17, 2018

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

News Daily News

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

Michael O'Riordan

April 16, 2018

State-by-State Analysis of CVD Burden Suggests Years of Progress May Be Sliding Back

News Daily News

State-by-State Analysis of CVD Burden Suggests Years of Progress May Be Sliding Back

April 13, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.